Use of Biotene Moisturizing Mouth Spray for Xerostomia Associated With Oral Oxybutynin Use
Status:
Withdrawn
Trial end date:
2019-12-30
Target enrollment:
Participant gender:
Summary
This is a randomized placebo controlled trial of the use of Biotene versus no treatment in
women receiving oral oxybutynin for overactive bladder. The primary outcome will be rate of
discontinuation of oxybutynin at 6 month.